Zelnorm Will Be Available Under Treatment IND Following Marketing Suspension
Novartis voluntarily suspends marketing of the irritable bowel syndrome medication due to cardiovascular events.
Novartis voluntarily suspends marketing of the irritable bowel syndrome medication due to cardiovascular events.